Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435734
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2020-11-05
First Post:
2007-02-14
Brief Title:
Obesity Intervention Obeldicks for Obese Children Adolescents and Their Parents
Sponsor:
University of WittenHerdecke
Organization:
University of WittenHerdecke
Study Overview
Official Title:
Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Obeldicks
Brief Summary:
The intervention program Obeldicks was developed for obese children aged 6 to 16 years This intervention is gender- and age specific The 12-months intervention is based on nutrition course behaviour therapy and exercise therapy The evaluation compromised quality of structure process and results of the intervention Primary outcome measure is change of weight status as standard deviation score of BMI Furthermore cardiovascular risk factor profile hormones eg iGF-I thyroid hormones vitamin D statusadipocytokines GI- hormones intima media thickness are measured prior to and after the one-year intervention The changes of these hormones and adipocytokines will allow to answer the questions whether the alterations of these hormones are a cause or consequence of overweight Additionally a genetic screening is performed to characterize the participants to probably predict response to intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None